Autoimmune Disease Treatments 2026 — Emerging Research
New autoimmune treatments in 2026: JAK inhibitors, precision immunotherapy, microbiome approaches. AI-analyzed across MS, lupus, RA, and Crohn's.
Standard of Care
Immunosuppressants (methotrexate, azathioprine), biologics (TNF inhibitors, IL-6 blockers, B-cell depleters), JAK inhibitors — primarily symptom control and flare prevention.
Prevalence
~24 million Americans affected by autoimmune diseases. Over 80 distinct conditions. Prevalence rising globally.
Research by Therapy Category
- Stem Cell Therapy Research
- Anktiva Immunotherapy Research
- Bioactive Peptide Research
- Gene Therapy & CRISPR Research
- Nutraceutical & Vitamin Research
- Antiparasitic Drug Repurposing Research
- Lifestyle Intervention Research
- Engineered Cell Therapy Research
- Off-Label Drug Repurposing Research
- Microbiome & Mitochondrial Intervention Research
- Diagnostic Test & Biomarker Research
- Computational Chemistry & Molecular Analysis
- Hormonal & Women's Health Research
- Disease Mechanism Education for Patients